Journal article
Post‐thrombotic syndrome in patients with venous thromboembolism treated with dabigatran or warfarin: A long‐term cross‐sectional follow‐up of RE‐COVER study patients
Abstract
BACKGROUND: Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to warfarin reduces the risk of post-thrombotic syndrome (PTS) after deep vein thrombosis (DVT), but this has not been evaluated for oral direct thrombin inhibitors.
OBJECTIVES: To compare the long-term prevalence of PTS, recurrent venous thromboembolism (VTE), and health-related quality of life (HRQoL) in patients with acute DVT and/or pulmonary embolism (PE), …
Authors
Wik HS; Kahn SR; Eriksson H; Morrison D; Ghanima W; Schulman S; Sandset PM
Journal
Journal of Thrombosis and Haemostasis, Vol. 19, No. 10, pp. 2495–2503
Publisher
Elsevier
Publication Date
October 2021
DOI
10.1111/jth.15449
ISSN
1538-7933